The Antioxidant Vitamins: Impact on Atherosclerosis

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

Volumn 13, Issue 6, 1993, Pages 574-582

  Meyers, David G ^a   Maloley, Pierre A ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; RETINOL;

ATHEROGENESIS; ATHEROSCLEROSIS; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; HUMAN; LIPID OXIDATION; PRIORITY JOURNAL; REVIEW; VITAMIN BLOOD LEVEL;

ANIMAL; ANTIOXIDANTS; ARTERIOSCLEROSIS; ASCORBIC ACID; CAROTENOIDS; ENDOTHELIUM, VASCULAR; HUMAN; LIPOPROTEINS, LDL; VITAMIN E;

EID: 0027381095     PISSN: 02770008     EISSN: 18759114     Source Type: Journal    
DOI: 10.1002/j.1875-9114.1993.tb02760.x     Document Type: Review

References (98)

1. Coronary heart disease: genetic aspects
2. Antioxidants and atherosclerosis: a current assessment
3. The pathogenesis of atherosclerosis—an update
4. The pathogenesis of atherosclerosis—an overview
5. Beyond cholesterol: modifications of low‐density lipoprotein that increases its atherogenicity
6. On the antioxidant hypothesis with regard to atherosclerosis
7. Lipoproteins and atherosclerosis: a look back and a look ahead
8. Receptor‐mediated catabolism of low‐density lipoprotein in man. Quantitation using glycosylated low‐density lipoprotein
9. Tissue sites of degradation of low‐density lipoprotein: application of a method for determining the fate of plasma protein
10. Lipoprotein metabolism in the macrophage. Implications of cholesterol deposition in atherosclerosis
11. Binding site on macrophage that mediates uptake and degradation of acetylated low‐density lipoprotein producing massive cholesterol deposition
12. Enhanced macrophage degradation of low‐density lipoprotein previously incubated with cultured endothelial cells: recognition by receptor for acetylated low‐density lipoproteins
13. Lipid peroxides and atherosclerosis
14. Oxidative status of lipoproteins in coronary disease patients
15. Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL: correlation with changes in receptor‐mediated catabolism
16. Recognition of solubilized apoproteins from dilapidated oxidized low‐density lipoprotein (LDL) by the acetyl‐LDL receptors
17. Minimally modified LDL stimulates monocyte endothelial interactions
18. Purification of a monocyte chemotactic factor (SMC‐CF) secreted by nonhuman primate vascular smooth muscle cells in culture
19. Oxidatively modified low‐density lipoproteins: a potential role in recruitment and retention of monocytes/macrophages during atherogenesis
20. Endothelial‐cell derived chemotactic activity for mouse peritoneal macrophages and the effects of modified forms of low‐density lipoprotein
21. Changes in the cells of atherosclerotic lesions as advanced lesions evolve in coronary arteries of children and young adults
22. Studies of hypercholesterolemia in the nonhuman primate. Changes that lead to fatty streak formation
23. Cholesterol net transport, esterification, and transfer of human hyperlipidemic plasma
24. Superoxide initiates oxidation of low‐density lipoprotein by human monocytes
25. Mechanisms of atherosclerosis—a review
26. Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggests it identify with macrophage‐derived growth factor
27. Platelet activation by oxidatively modified low‐density lipoprotein
28. Platelet secretory products increase low‐density lipoprotein oxidation, enhance its uptake by macrophages, and reduces its fluidity
29. Inflammatory components of the human atherosclerotic plaque
30. Vitamin E. Antioxidant activity, biokinetics, and bioavailability
31. Interaction of oxygen and oxy‐radicals with carotenoids
32. Beta carotene: an unusual type of lipid antioxidant
33. The effect of vitamin C on in vivo lipid peroxidation in guinea pigs as measured by pentane and ethane production
34. Antioxidants carried by lipoproteins
35. Role of beta‐carotene in the oxidative modification of low‐density lipoproteins
36. Association between dietary changes and mortality rates. Israel 1949 to 1977, a trend‐free regression model
37. Plasma vitamins E and A inversely correlated to mortality from ischemic heart disease in cross‐cultural epidemiology
38. Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease
39. Serum selenium, vitamin antioxidants and cardiovascular mortality: a 9–year follow‐up study in The Netherlands
40. Risk of angina pectoris and plasma concentrations of vitamins A, C, and E, and carotene
41. The relation of diet, cigarette smoking, and alcohol consumption to plasma beta‐carotene and alpha‐tocopherol levels
42. Beta‐carotene therapy for chronic stable angina [abstr]
43. Vitamin E consumption and the risk of coronary heart disease in men
44. Plasma levels of antioxidant vitamins in relation to ischemic heat disease and cancer
45. Vitamins lecithin and additives
46. Antioxidant and co‐antioxidant effect of vitamin C. The effect of vitamin C, either alone or in the presence of vitamin E or a water soluble vitamin E analogue, upon the peroxidation of aqueous multilamellar phospholipid liposomes
47. Therapeutic potential of vitamin E in the pathogenesis of spontaneous atherosclerosis
48. Alpha‐tocopherol consumption during low‐density lipoprotein oxidation
49. Relationship of plasma level of vitamin C to mortality from ischemic heart disease
50. Vitamin E antioxidants and lipid peroxidation in experimental atherosclerosis of rabbits
51. Dietary supplementation with vitamin E in hyperlipoproteinemia: effects on plasma lipid peroxides, antioxidant activity, prostacyclin generation and platelet aggregability
52. Actions of vitamins A and E and some nicotinic acid derivatives on plasma lipids and on lipid infiltration of aorta in cholesterol‐fed rabbits
53. Effect of dietary vitamin E on plasma lipids and atherogenesis in restricted ovulation chickens
54. Atherosclerosis in cholesterol‐fed Japanese quail: evidence for amelioration by dietary vitamin E
55. Plasma vitamin A and E in the study of lipid and lipoprotein metabolism in coronary heart disease
56. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross‐cultural epidemiology
57. Vitamin E in angina pectoris
58. Failure of alpha‐tocopherol to influence chest pain in patients with heart disease
59. Vitamin E and cardiovascular disease
60. Vitamin E improved myocardial protection [abstr]
61. Vitamin E consumption and the risk of coronary disease in women
62. The relative contributions of vitamin E, urate, ascorbic acid, and proteins to the total peroxyl radical‐trapping antioxidant in human blood plasma
63. Ascorbate is an outstanding antioxidant in human blood plasma
64. Action of ascorbic acid as a scavenger of active and stable oxygen radicals
65. Vitamin C and cardiovascular disease: a review
66. Aging, atherosclerosis and ascorbic acid metabolism
67. An experimental study of the intimal ground substance in atherosclerosis
68. The role of ascorbic acid in the regulation of cholesterol metabolism and in the pathogenesis of atherosclerosis
69. Decline of coronary mortality in the United States and vitamin C
70. Ischemic heart disease mortality and dietary intake of calcium
71. Commodity consumption and ischemic heart disease mortality, with special reference to dietary practice
72. Diet and peripheral arterial occlusive disease. The role of poly‐, mono‐, and saturated fatty acids
73. Leukocyte ascorbic acid and its relationship to coronary artery disease in man
74. Ascorbic acid content of human arterial tissue
75. Mortality among health‐conscious elderly Californians
76. The relationship between vitamin C intake, general health practices, and mortality in Alameda County, California
77. Nutritional status of the aging
78. Vitamin C intake and mortality among a sample of the United States population
79. Effect of vitamin C and E supplementation on susceptibility of plasma lipoproteins to peroxidation induced by acute smoking
80. Serial arteriography in atherosclerosis
81. Ascorbic acid in cholesterol and bile metabolism
82. Ischemic heart disease and aged patients: effects of ascorbic acid on lipoproteins
83. Vitamin C therapy in hyperlipoproteinemia
84. Effect of dietary eggs and ascorbic acid on plasma lipid and lipoprotein cholesterol levels in healthy young men
85. HDL cholesterol and vitamin C status
86. Relationships among dietary constituents and specific serum clinical components of subjects eating self‐selected diets
87. A comparison of prospective and retrospective assessments of diet in this study of breast cancer [abstr]
88. Vitamin A, β‐carotene, and the risk of cancer, a prospective study
89. Dietary vitamin A and risk of cancer in the Western Electric study
90. Vitamin supplement use by demographic characteristics
91. Nutrient intake and supplementation in the United States (NHANES‐II)
92. Antioxidant vitamins and coronary heart disease